Papillary thyroid carcinoma post total thyroidectomy: a case report

  • Darwito Academic Hospital Universitas Gadjah Mada, Yogyakarta, Indonesia
  • Doglas Rama Bayu Ardha Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • Ika Puspita Sari Academic Hospital Universitas Gadjah Mada/Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
  • Firda Ridhayani Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
Keywords: FNAB, PTC, RAI, recurrence, total thyroidectomy


Thyroid malignancies are considered rare but it is the most common type of endocrine malignancy that increase rapidly over the past decades. Specifically, papillary thyroid carcinoma (PTC) in the pyramidal lobe is extremely rare. Herein, we described a case of recurrence case of PTC in the pyramidal lobe post total thyroidectomy with category VI T2N1M1 (Bethesda classification) with right neck lymph nodes metastasis at once and attempt to determine both clinical presentation and therapeutical strategies to overcome this case to diminish the possibility of tumor recurrence and optimize therapeutic outcomes for PTC recurrence. It was reported a 28 yo female with a diagnosis of PTC from the pyramidal lobe post-total thyroidectomy procedure. A definite diagnosis of PTC is important to understand the patient's condition and as a consideration to decide the appropriate procedure to cure it. The management of PTC with total thyroidectomy followed by removing the possible root source of recurrent PTC, such as the pyramidal lobe, is mandatory to minimize the residual thyroid tissue that dan influenced PTC recurrent. Even though almost all PTC has an excellent prognosis, periodic follow-up after surgery, and patients’ adherence to their medication are still required.



Hadmoko ST, Nirmawati K, Pranoto A. Recurrent Papillary Thyroid Carcinoma Posttotal Thyroidectomy With Lung And Neck Lymph Node Metastases. Journal of Health and Translational Medicine (JUMMEC). 2023 Feb 27;26(1):76–81.

Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. The Lancet Diabetes & Endocrinology. 2021 Apr 1;9(4):193–4.

Negura I, Ianole V, Danciu M, Preda C, Iosep DG, Dănilă R, et al. Thyroid Collision Tumors: The Presence of the Medullary Thyroid Carcinoma Component Negatively Influences the Prognosis. Diagnostics. 2023 Jan;13(2):285.

Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016 Nov;12(11):646–53.

Limaiem F, Rehman A, Anastasopoulou C, Mazzoni T. Papillary Thyroid Carcinoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 May 25]. Available from:

Lloyd RV, Buehler D, Khanafshar E. Papillary Thyroid Carcinoma Variants. Head Neck Pathol. 2011 Jan 8;5(1):51–6.

Messias H, Sequeira ML, Nogueira R, Zagalo C, Martins M, Gomes P. Pyramidal lobe‐dominant papillary thyroid carcinoma—A rare entity with important clinical implications. Clin Case Rep. 2023 May 16;11(5):e7189.

Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS. Follicular Variant of Papillary Thyroid Carcinoma is a Unique Clinical Entity: A Population-Based Study of 10,740 Cases. Thyroid. 2013 Oct;23(10):1263–8.

Chen H, Udelsman R. Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin N Am. 1998 Oct;7(4):645–63.

Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology. 2019 Dec 1;30(12):1856–83.

Amoako-Tuffour Y, Graham ME, Bullock M, Rigby MH, Trites J, Taylor SM, et al. Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: a case report. Thyroid Res. 2017 Oct 10;10:8.

Sun JH, Li YR, Chang KH, Liou MJ, Lin SF, Tsai SS, et al. Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan. Biomedical Journal. 2022 Dec 1;45(6):923–30.

Shah JP. Thyroid Carcinoma: Epidemiology, Histology, and Diagnosis. Clin Adv Hematol Oncol. 2015 Apr;13(4 Suppl 4):3–6.

Lukovic J, Petrovic I, Liu Z, Armstrong SM, Brierley JD, Tsang R, et al. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome. Frontiers in Endocrinology [Internet]. 2021 [cited 2023 Feb 11];12. Available from:

Shin JH. Ultrasonographic imaging of papillary thyroid carcinoma variants. Ultrasonography. 2017 Apr;36(2):103–10.

Wang M, Zou X, Li Z, Zhu J. Recurrence of papillary thyroid carcinoma from the residual pyramidal lobe: a case report and literature review. Medicine (Baltimore). 2019 Apr 12;98(15):e15210.

Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017 Nov;27(11):1341–6.

Han L, Li W, Li Y, Wen W, Yao Y, Wang Y. Total thyroidectomy is superior for initial treatment of thyroid cancer. Asia Pac J Clin Oncol. 2021 Oct;17(5):e170–5.

Chan S, Karamali K, Kolodziejczyk A, Oikonomou G, Watkinson J, Paleri V, et al. Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer. European Thyroid Journal. 2020 Feb 1;9(2):73–84.

Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated Thyroid Cancer-Treatment: State of the Art. Int J Mol Sci. 2017 Jun 17;18(6):1292.

Miccoli P, Materazzi G, Rossi L. Levothyroxine Therapy in Thyrodectomized Patients. Front Endocrinol (Lausanne). 2021 Jan 29;11:626268.

Ahn D, Lee GJ, Sohn JH, Jeon JH. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma. Head Neck. 2020 May;42(5):1004–13.

Karakozis S. Management of complications after thyroid surgery. Hellenic J Surg. 2015 Jan 1;87(1):115–7.

Bumber B, Potroško V, Vugrinec O, Ferenčaković M, Gršić K. Hypocalcemia After Completion Thyroidectomy for Papillary Thyroid Carcinoma. Acta Clin Croat. 2020 Jun;59(Suppl 1):136–45.

Cataldo E, Columbano V, Nielsen L, Gendrot L, Covella B, Piccoli GB. Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature. BMC Nephrology [Internet]. 2018 [cited 2023 May 25];19. Available from: